Molecular Testing

Trilab Health has partnered with MSGI and ThermoFischer, the foremost leaders in the industry to create proprietary Lab Developed Tests (LDT) using high throughput automation systems. Trilab is at the forefront of providing care to Women’s Health, Wound Care, UTI and Respiratory testing.  

Molecular diagnostics is quickly replacing the gold-standard in diagnostics for infectious diseases by providing the necessary sensitivity, specificity, and turnaround time to support the decision-making process and enable better patient management. 

Over 75

Individual Molecular Tests Performed

Over 100,000

Patients Cared For

Over 100,000

Molecular Tests Performed

Wound Care

Trilab works with prominent primary, post, and urgent care centers to minimize turnaround times and optimize clinical decision-making.  

Advancements in molecular diagnostic medicine allow for the identification of nearly all organisms present within a wound, irrespective of the ability of these organisms to be grown in culture. 

Wound care can be both chronic and acute. Advances in PCR allow for absolute identification of these microorganisms from very small sample sizes. PCR can also provide a quantitative representation of all microorganisms contributing to these polymicrobial infections.  

These advances significantly shorten the time required to identify and treat chronic or acute wounds  As a result practitioners will experience better patient outcomes and care quality metrics.

Women's Health And STI

Women’s health is an important part of diagnostic medicine as health needs change at every age and stage of life. Clinicians are faced with increasing challenges in managing patient needs when it comes to reproductive health. Staggering costs to the U.S. healthcare system caused by the growing number of new infections demand action in the way we test for sexually-transmitted infections (STIs).

  • For vaginal infections, traditional diagnostics leave up to 40% of women with vaginitis undiagnosed after an initial clinical visit.
  • Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV) are the most prevalent non-viral causes of sexually transmitted infections and accounted for ~$1.1 billion in direct medical costs in 2018.
  • Screening and early detection of HPV and HSV can avoid the downstream consequences of untreated STIs. 

UTI

UTI’s are a result of bacteria that can go to any part of your urinary system including your kidneys, bladder, ureters, and urethra. Trilab Health uses PCR to detect drug resistance markers and identify organisms.

Repeated UTI’s can have a deep and lasting impression and be difficult to diagnose. Often, patients are treated on symptoms alone but the diagnosis of UTI by clinical criteria alone has an error rate of approximately 33%.

Mutli-drug resistant organisms develop over time in a population due to repeated use of prophylactic antibiotics to fight infections. As organisms develop resistance to antibiotics, it becomes more important to treat based on specific organism and resistance.

Molecular based diagnosis can identify the cause of UTI within hours. UTI pathogens are not only detected with greater accuracy but our tests are able to provide treatment specifics. 

Respiratory

With SARS CoV-19 still prominent in todays world it can be difficult to distinguish between the many pathogens responsible for a upper or lower respiratory infection.  

Our Respiratory testing includes: 

  • SARS CoV-19 two gene testing along with the option to test for Influenzae A and B to help provider decision making 
  • We offer individual testing as well as respiratory panel testing for use during flu season and upticks in other common infections.  
0

current US nursing home residents had pressure ulcers

0 Million

Total positive test women have a sexually transmitted infection (STI) on any given day

0 %

of women in the United States will develop a urinary tract infection (UTI) at some point in their lifetime

  1. Acinetobacter baumannii
  2. Citrobacter freundii
  3. Enterobacter aerogenes
  4. Enterobacter cloacae
  5. Enterococcus faecalis
  6. Enterococcus faecium
  7. Escherichia coli
  8. Klebsiella oxytoca
  9. Klebsiella pneumoniae
  10. Morganella morganii
  11. Proteus mirabilis
  12. Proteus vulgaris
  13. Staphylococcus aureus
  14. Candida albicans
  15. Candida glabrata
  16. Candida parapsilosis
  17. Candida tropicalis
  18. Bacteroides fragilis
  19. Citrobacter braakii
  20. Clostridium novyi
  21. Clostridium perfringens
  22. Clostridium septicum
  23. Kingella kingae
  24. Psuedomonas aeruginosa
  25. Streptococcus pyogenes
  1. Acinetobacter baumannii
  2. Actinobaculum schaalii
  3. Aerococcus urinae
  4. Alloscardovia Omnicolen
  5. Citrobacter freundii
  6. Coagulase-negative
  7. Corynebacterium riegelii
  8. Enterobacter aerogenes
  9. Enterobacter cloacae
  10. Enterococcus faecalis
  11. Enterococcus faecium
  12. Escherichia coli
  13. Klebsiella oxytoca
  14. Klebsiella pneumoniae
  15. Morganella morganii
  16. Mycoplasma hominis
  17. Proteus mirabilis
  18. Proteus vulgaris
  19. Providencia stuartii
  20. Pseudomonas aeruginosa
  21. Serratia marcescens
  22. Staphylococci
  23. Staphylococcus aureus
  24. Staphylococcus saprophyticus
  25. Streptococcus agalactiae
  26. Viridans Group Strep
  27. Candida albicans
  28. Candida glabrata
  29. Candida parapsilosis
  30. Candida tropicalis
  1. Atopobium vaginae
  2. Bacteroides fragilis
  3. BVAB2
  4. Mycoplasma hominis
  5. Gardnerella vaginalis
  6. Haemophilus ducreyi
  7. Lactobacillus crispatus
  8. Lactobacillus gasseri
  9. Lactobacillus iners
  10. Lactobacillus jensenii
  11. Megasphera 1
  12. Megasphera 2
  13. Mobiluncus curtisii
  14. Mobiluncus mulieris
  15. Ureaplasma urealyticum
  16. Prevotella bivia
  17. Enterococcus faecalis
  18. Candida albicans
  19. Candida dubliniensis
  20. Candida glabrata
  21. Candida krusei;Pichia kudriavzevii
  22. Clavispora lusitaniae;SKN7
  23. Candida parapsilosis
  24. Candida tropicalis
  25. Mycoplasma genitalium
  26. Chlamydia trachomatis
  27. ALPHA-TUB1;Trichomonas vaginalis
  28. HSV1
  29. HSV2
  30. Neisseria gonorrhoeae
  31. Treponema pallidum (Syphilis)
  32. Staphylococcus aureus
  33. Streptococcus agalactiae
  34. Escherichia coli
  1. Mycoplasma hominis
  2. Gardnerella vaginalis
  3. Haemophilus ducreyi
  4. Ureaplasma urealyticum
  5. Mycoplasma genitalium
  6. Chlamydia trachomatis
  7. HSV1
  8. HSV2
  9. Neisseria gonorrhoeae
  10. Treponema pallidum
  11. Trichomonas vaginalis
  12. Human papillomavirus 16
  13. Human papillomavirus 18
  1. SARS – COVID 19
  2. Influenza A
  3. Influenza B

Drug Resistance Tests

Drug resistance testing allows providers to focus their treatment with effective antibiotics. This not only reduces time to recovery but can lower rates of complication as well as help minimize development of multi-drug resistant infections  

  • mecA
  • AmpC
  • Carbapenem (BlaKPC)
  • ESBL (blaCTX-M)
  • Macrolide (Mef(A))
  • Quinolone-Fluoroquinolone (qnrA, qnrS)
  • Vancomycin (VanA1, VanA2, VanB)
  • Tetracyclin

What sets Trilab Health apart?

Trilab maintains it stand at the forefront of new developments in molecular diagnostics testing, so our partners

can provide the best combination of therapeutic options to their patients. The foundation of our lab is centered

around quality, efficiency and access.

Trilab Trifecta - QEA

Quality

by providing precision results with sensitivities and specificities while maintaining CLIA/COLA Accreditations and internal Quality Metrics to ensure accurate results are delivered every time.

Efficiency

Trilab maintains industry leading turnaround times on all testing that not only minimizes our partners time to treat but enables for accurate treatment the first time. We optimize our processes using sigma six to ensure that your providers have their results when they need them.

Access

Trilab not only provides accurate results through multiple different mediums of exchange from HL7 to easy access portals, but opens your door to a plethora of academic information. Providing peer-to-peer discussions, industry standard updates and academic updates when you need them. You have access to an industry leading team of experts to assist you from clinical to pharmaceutical needs.

Contact Us